Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Drug Alcohol Depend. 2019 Oct 21;205:107648. doi: 10.1016/j.drugalcdep.2019.107648

Table 7.

At Least One-Level Reduction in Frequency Level as a Predictor of 6- and 12- Month Outcomes

6-Month Outcomes
               At Least One-Level Reduction in Frequency Level?
NO
(i.e., no change/increase in
frequency level)
n = 329
YES
(i.e., reduced 1 or 2
frequency levels)
n = 197
B (SE) Means (SD) or N (%) Effect Size
ASI Cocaine −.12 (.03)** .39 (.30) .25 (.26) d=.49
ASI Other Drug Use −.009 (.008) .05 (.08) .03 (.07) d=.26
ASI Alcohol −.004 (.01) .05 (.12) .07 (.13) d=.15
ASI Medical .01 (.01) .09 (.22) .09 (.21) d=0
ASI Psychological −.04 (.01)* .17 (.21) .12 (.17) d=.26
ASI Family −.01 (.01) .10 (.16) .09 (.13) d=.06
ASI Employment −.07 (.02) .67 (.27) .57 (.27) d=.37
ASI Legal −.04 (.008)** .08 (.16) .03 (.11) d=.36
Cocaine Use Days −.4.32 (.57)** 7.02 (8.77) 3.05 (5.7) d=.53
Cocaine Negative Urine .68 (.06)** 97 (34%) 95 (59.7%) OR = 1.95
12-Month Outcomes
              At Least One-Level Reduction in Frequency Level?
 NO
n = 156
   YES
n = 145
ASI Cocaine −.09 (.04) .31 (.27) .21 (.23) d=.39
ASI Other Drug Use −.01 (.003)* .04 (.08) .02 (.07) d=.26
ASI Alcohol .003 (.01) .07 (.15) .08 (.14) d=.06
ASI Medical .01 (.01) .08 (.21) .09 (.25) d=.04
ASI Psychological −.04 (.01)* .14 (.20) .09 (.15) d=.28
ASI Family .00 (.02) .12 (.17) .12 (.16) d=0
ASI Employment −.08 (.01)** .63 (.26) .55 (.24) d=.31
ASI Legal .003 (.02) .04 (.11) .05 (.13) d=.08
Cocaine Use Days −.2.02 (.32)** 5.4 (7.6) 3.4 (6.38) d=.28
Cocaine Negative Urine .26 (.10) 56 (43%) 59 (56.7%) OR = 1.29

Note.

*

p≤0.01.

**

p≤0.001.

B = Unstandardized regression coefficient. SD = standard deviation. SE = standard error. d= Cohen’s d. OR = Odds Ratio. EOT = End of Treatment. ASI = Addiction Severity Index. In all models, we controlled for age, gender, race, education status, and baseline cocaine frequency level. For all models with ASI composites as the outcome, we also controlled for the baseline value of the ASI outcome.